Protein S-Leu17Pro disrupts the hydrophobicity of its signal peptide causing a proteasome-dependent degradation

Kentaro Okada1, Shogo Tamura1, Nobuaki Suzuki2

  • 1Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Thrombosis Research
|December 30, 2021
PubMed

Insights

A novel protein S gene variation (PROS1-L17P) causes protein S deficiency by disrupting its signal peptide. This leads to mislocalization and proteasome-dependent degradation, explaining thrombophilia.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Protein S is a vital glycoprotein with anticoagulant and protective functions.
  • Congenital protein S deficiency, a thrombophilia, arises from variations in the PROS1 gene.
  • A specific PROS1 variation, c.50 T > C (p.Leu17Pro), was identified as a cause of protein S deficiency.

Purpose of the Study:

  • To investigate the molecular mechanisms by which the PROS1-L17P variation leads to protein S deficiency.
  • To analyze the impact of the L17P substitution on protein S signal peptide function and cellular processing.

Main Methods:

  • In silico analysis of signal peptide hydrophobicity and cleavage site.
  • Recombinant protein S expression in HEK293 and COS-7 cells.
  • Analysis of intracellular kinetics and extracellular secretion using western blotting and immunocytochemistry, including proteasome inhibitor treatment.

Main Results:

  • The L17P substitution disrupted the hydrophobic h-region of the protein S signal peptide.
  • Recombinant protein S-L17P was undetectable extracellularly but detected intracellularly upon proteasome inhibition.
  • Absence of N-glycosylation indicated failure of translocation to the endoplasmic reticulum, with cytosolic mislocalization and degradation.

Conclusions:

  • The PROS1-L17P variation directly causes protein S deficiency.
  • Protein S-L17P undergoes cytosolic mislocalization and subsequent proteasome-dependent degradation.
  • This molecular mechanism explains the associated autosomal dominant thrombophilia.
Abstract

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.0K
Insertion of Single-pass Transmembrane Proteins in the RER01:26

Insertion of Single-pass Transmembrane Proteins in the RER

Integral membrane proteins are proteins adhered to the lipid bilayer of a cell organelle or membrane. They can be of two types: transmembrane integral proteins that span the lipid bilayer and monotopic proteins that are attached to either side of the membrane but do not pass through it.
Integral transmembrane proteins possess transmembrane and extra membrane domains. The transmembrane domains are primarily made of 20-25 hydrophobic amino acids arranged in a helical secondary confirmation. These...
11.5K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.1K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.8K
Directing Proteins to the Rough Endoplasmic Reticulum01:34

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
11.6K